Immunoprofiling of drug-resistant epilepsy with a focus on glutamic acid decarboxylase 65 antibodies
<p>The urgent need to improve therapies for people with drug-resistant epilepsy (DRE) requires improved understanding of the aetiopathophysiology of epilepsy and the mechanisms responsible for pharmacoresistance. Autoantibody-mediated processes may explain DRE in a proportion of cases. Autoa...
| Glavni autor: | |
|---|---|
| Daljnji autori: | |
| Format: | Disertacija |
| Jezik: | English |
| Izdano: |
2021
|
| Teme: |